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multiple aliquots were stored at exactly 1 h after collection at 80 C
pendinganalysis.Asdemonstratedbyothers, concentrationandactivity
of MMP is stable during long term storage at80 C.1
Assays
Plasma levels of MMP- 2, -9 and TIMP-1 were determined
by means of a commercially available enzyme linked immunosor-
bent assay (GE Healthcare/lifesciences, Upssala, Sweden) according
to themanufacturer’s guidelines and were determined in duplicate.
Duplicates with less than 10% within assay variation in concentra-
tion were accepted and means were determined for further anal-
ysis. The between-assay variation (7% for MMP-2, 10% for both
MMP-9 and TIMP-1) was determined by the manufacturer.Yours faithfully,Reference
1 Sulik, A., Wojtkowska, M. & Oldak, E. 2008. Preanalytical factors affecting the
stability of matrix metalloproteinase-2 concentrations in cerebrospinal ﬂuid.
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doi:10.1016/j.ejvs.2012.02.001Factors Affecting Amputation-free Survival Rates in Critical
Limb IschemiaDOI of original article: 10.1016/j.ejvs.2012.01.034.First of all, we would like to congratulate the authors upon their
study investigating the factors affecting amputation-free survival in
the patients with critical limb ischemia (CLI).1 Cilostazol is not
mentioned among the medical treatment protocols provided to the
patients in the article, whereas there are a number of studies report-
ing lower amputation rates upon cilostazol administration in the
patients with CLI who had undergone endovascular intervention.2,3
Moreover, cilostazol administration was also documented to pull
down the amputation rates even in the cases with CLI in whom no
intervention was undertaken.4,5 Therefore, we believe the
amputation-free survival rates emerging in the present study would
be more accurate if an evaluation is made by taking into consider-
ation that cilostazol is not used in the study. Likewise, we also noted
in the study that extra-anatomic by-pass (EAB) procedure is imple-
mented in 3 out of 15 patients undergoing revascularization due to
ischemic pain. If EAB was undertaken in these patients during the
ﬁrst surgical intervention, what was the actual reason behind? If
EAB procedurewas preferred in these patients owing to the presence
of previous surgical operation, do you think the previous history ofvascular surgery had an impact on the amputation rates?We believe
that evaluation of the present study would be comprehended much
more thoroughly by keeping all the aforementioned issues in mind.
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doi:10.1016/j.ejvs.2012.01.034Response to Letter to the Editor: Factors Affecting Amputation-
Free Survival Rates in Critical Limb IschemiaWe appreciate the comments concerning our article on
amputation-free survival in patients with CLI.
We collected our data in 2004 and 2005. At that time, cilostazol
was not yet approved for treatment of patients with PAD, in
Germany. Therefore, we do not have any data concerning the inﬂu-
ence of cilostazol on amputation-free survival in our study popula-
tion. Nevertheless, we agree with the authors that cilostazol mighth-
a-
ve
Correspondence / European Journal of Vascular and Endovascular Surgery 43 (2012) 610–613612a positive effect on outcome in patients following revascularisation.
But we cannot comment on this on the basis of our data. Further-
more, to our knowledge cilostazol is approved only for claudicants,
not however for patients with CLI, in Europe. Therefore, we believe
our data reﬂect the local situation.
The three patients with extra-anatomic reconstructions were
considered too frail for aortic surgery and therefore received extra-
anatomic revascularisations as primary operation. None oft the
patients had undergone previous vascular surgery, as we described
initial treatment inpatients presentingwith theirﬁrst episode of CLI.M. Engelhardt*
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doi:10.1016/j.ejvs.2012.02.004Response to Letter to the Editor Re “What are the Risk Factors
for Renal Failure Following Open Elective Abdominal Aortic
Aneurysm Repair?”
We would like to thank the authors of the letter for their
comments regarding ourmanuscript.1 We agree that intraoperative
blood loss and subsequent transfusion are likely to be important
risk factors for the development of post-operative renal failure
following major surgery of all types. The aim of this study was
however to identify the pre-operative risk factors associated with
post-operative renal failure following open elective abdominal
aortic aneurysm (AAA) repair. The ability to identify high-risk
patients pre-operatviely is important as renal optimisation strate-
gies, including the avoidance of nephrotoxic agents in the peri-
operative period and the use of autotransfusion, can be decided
on prior to surgery. At our centre autotransfusion use is routine
for open elective AAA repair. It is also being used increasingly
throughout the North West of England with cell salvage utilised
for 30% of open elective AAA repairs between 2000 and 2005 and
for 47% of cases between 2006 and 2010 (OR 2.07, 95%CI 1.75–
2.46, p < 0.001, c2).
We agree with Gokalp and colleagues that it is also important
to identify the modiﬁable peri-operative risk factors that are asso-
ciated with the development of post-operative renal failure. One
of the most signiﬁcant peri-operative risk factors for renal failure
on univariate analysis in our cohort is the return to theatre for
bleeding with renal failure occurring in 21.3% of patients
requiring re-operation compared to 4.9% of patients who did
not require re-operation (OR 5.27, 95%CI 3.43–8.11, p < 0.001,
c2). Further analyses of the peri-operative risk factors that are
associated with the development of post-operative renal failure
are planned.I of original article: 10.1016/j.ejvs.2012.02.021. DOI of original article: 10.1016/j.ejvs.2012.02.019.DOReference
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doi:10.1016/j.ejvs.2012.02.019Factors Affecting the Development of Renal Failure after
Abdominal Vascular Surgery
We congulatulate the authors for the study about the predispos-
ing rick factors of renal disfunction following elective abdominal
aortic aneurysm repair.1 We believe that the effect of perioperative
blood transfusion onpostoperative renal failure should be evaluated
in this large study group as well, regarding many papers suggesting
this result for either cardiac or noncardiac surgery.2–4 If the relation
between blood transfusion and postoperative renal failure can be
shown especially for major abdominal vascular surgery, methods
like autotransfusion should be considered carefully and at length.References
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